Grade My Investments
HomeFree Stock Grades › IDXX

IDEXX Laboratories, Inc. (IDXX) Stock Grade

IDXX · Healthcare

A+
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$43.5B
P/E Ratio
51.2
Revenue Growth (YoY)
+10.4%
Net Margin
24.6%
Return on Equity
66.0%
Dividend Yield
None

About IDEXX Laboratories, Inc.'s fundamentals

IDEXX Laboratories is a large-cap diagnostic company with a market capitalization of $54.2 billion that has demonstrated solid revenue growth of 10.4% year-over-year. The company operates with strong profitability metrics, posting a net margin of 24.6% and generating an exceptional return on equity of 66.0%, indicating efficient use of shareholder capital. Trading at a P/E ratio of 51.2, the valuation reflects a significant premium to the broader market. The company does not currently pay a dividend, retaining all earnings for reinvestment or other capital allocation purposes.

Track IDXX free — no credit card required. Live grade + monthly AI report →